Oct 20, 2022 | Government Investigations, Health Care Fraud
On October 18, the Department of Justice announced that for-profit home health provider Carter Healthcare LLC, along with its affiliates CHC Holdings and Carter-Florida (collectively Carter Healthcare), their President Stanley Carter, and Chief Operations Officer...
Oct 5, 2022 | Health Care Fraud
On September 26, the Department of Justice (DOJ) announced a Cambridge, MA pharmaceutical company, Biogen Inc. (Biogen), has agreed to pay approximately $900 million to resolve allegations that the company gave doctors kickbacks to encourage them to prescribe Biogen...
Sep 29, 2022 | False Claims Act, Government Investigations, Health Care Fraud
On September 26, 2022, the Department of Justice (DOJ) announced that pharmaceutical giant Biogen, Inc. agreed to pay $900 million to resolve allegations that it violated the False Claims Act (FCA) by paying prescribing physicians kickbacks in exchange for prescribing...
Sep 7, 2022 | Health Care Fraud
On September 2, the Department of Justice announced, “Bayer Corporation, an Indiana corporation and manufacturer of pharmaceutical products, and its related entities, Bayer HealthCare Pharmaceuticals Inc., Bayer HealthCare LLC and Bayer AG (collectively “Bayer”), have...
Aug 31, 2022 | Health Care Fraud
On August 25, 2022, the Eleventh Circuit upheld the convictions of a former Alabama physician, Patrick Ifediba, and his sister, Ngozi Justina Ozuligbo, who was a nurse who worked at a clinic run by her brother. They were charged and convicted of health care fraud,...
Aug 17, 2022 | Health Care, Health Care Fraud
In June 2022, the U.S. Supreme Court issued an opinion in Ruan v. United States that clarified the mens rea requirement for those who manufacture, distribute, or dispense drugs and are subsequently prosecuted under the Controlled Substances Act, specifically 21 U.S.C....
